Overview

Neural Circuit Effects of Ketamine in Depression

Status:
RECRUITING

Trial end date:
2028-04-30

Target enrollment:

Participant gender:

Summary

This project is designed to examine the role of the subgenual anterior cingulate cortex (sgACC) in anhedonia and anxiety in humans with depression, as well as the acute and sustained effects of ketamine on agACC activation and depression symptoms.

Phase:

PHASE4

Details

Lead Sponsor:

Icahn School of Medicine at Mount Sinai

Collaborator:

National Institute of Mental Health (NIMH)

Treatments:

Ketamine